Ezetimibe alone and in combination lowers the concentration of small, dense low-density lipoproteins in type 2 diabetes mellitus. [electronic resource]
Producer: 20120420Description: 189-93 p. digitalISSN:- 1879-1484
- Aged
- Analysis of Variance
- Anticholesteremic Agents -- therapeutic use
- Atherosclerosis -- blood
- Azetidines -- therapeutic use
- Biomarkers -- blood
- Centrifugation, Density Gradient
- Diabetes Mellitus, Type 2 -- blood
- Down-Regulation
- Drug Combinations
- Ezetimibe
- Ezetimibe, Simvastatin Drug Combination
- Female
- Germany
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Linear Models
- Lipoproteins, LDL -- blood
- Male
- Middle Aged
- Risk Assessment
- Risk Factors
- Simvastatin -- therapeutic use
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase IV; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.